Magnetic
resonance contrast agent employs the use of gadolinium
chelates, which has many limitations for clinical use including a
low contrast effect, a short diagnostic window, and a brief blood
circulation time. On this basis, we designed a gadolinium-labeled
dendrimer nanocluster (GdDN) loaded graphene oxide nanosheet (GO-GdDN)
to boost T
1 contrast ability for imaging
in vivo and improve blood circulation time. GO-GdDN presented an ultrahigh r
1 relaxivity up to 19.07 mM–1 s–1 in a 9.4 T MR scanner, and a bright contrast
image in vitro experiment. In addition, GO-GdDN could be internalized
by HepG2 cells and presented strong cell contrast enhancement and
reduction of the T
1 value in HepG2 cells.
In vivo, the retention time of GO-GdDN was significantly improved,
so that the accumulation of GO-GdDN in liver was enhanced. Moreover,
compared to Gd-DTPA, systemic delivery of GO-GdDN dramatically enhanced
the signal-to-noise ratio of liver images, which was helpful for accurate
imaging of liver and detection of liver lesions in vivo. Thus, this
study demonstrates the utility of a powerful diagnosis tool for liver
tumor or lesions.